Literature DB >> 31694519

Virtual Screening of Potential Anti-fatigue Mechanism of Polygonati Rhizoma Based on Network Pharmacology.

Ze-Feng Wang1, Ye-Qing Hu2, Qi-Guo Wu1, Rui Zhang3.   

Abstract

BACKGROUND AND
OBJECTIVE: A large number of people are facing the danger of fatigue due to the fast-paced lifestyle. Fatigue is common in some diseases, such as cancer. The mechanism of fatigue is not definite. Traditional Chinese medicine is often used for fatigue, but the potential mechanism of Polygonati Rhizoma (PR) is still not clear. This study attempts to explore the potential anti-fatigue mechanism of Polygonati Rhizoma through virtual screening based on network pharmacology.
METHODS: The candidate compounds of PR and the known targets of fatigue are obtained from multiple professional databases. PharmMapper Server is designed to identify potential targets for the candidate compounds. We developed a Herbal medicine-Compound-Disease-Target network and analyzed the interactions. Protein-protein interaction network is developed through the Cytoscape software and analyzed by topological methods. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment are carried out by DAVID Database. Finally, we develop Compound-Target-Pathway network to illustrate the anti-fatigue mechanism of PR.
RESULTS: This approach identified 12 active compounds and 156 candidate targets of PR. The top 10 annotation terms for GO and KEGG were obtained by enrichment analysis with 35 key targets. The interaction between E2F1 and PI3K-AKT plays a vital role in the anti-fatigue effect of PR due to this study.
CONCLUSION: This study demonstrates that PR has multi-component, multi-target and multipathway effects. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  E2F1; Fatigue; KEGG; PI3K-AKT; network pharmacology; polygonati rhizoma (PR).

Mesh:

Substances:

Year:  2019        PMID: 31694519     DOI: 10.2174/1386207322666191106110615

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  5 in total

1.  Network Pharmacology Exploration Reveals Gut Microbiota Modulation as a Common Therapeutic Mechanism for Anti-Fatigue Effect Treated with Maca Compounds Prescription.

Authors:  Hongkang Zhu; Ruoyong Wang; Hanyi Hua; Yuliang Cheng; Yahui Guo; He Qian; Peng Du
Journal:  Nutrients       Date:  2022-04-07       Impact factor: 6.706

2.  Network Pharmacology with Experimental Investigation of the Mechanisms of Rhizoma Polygonati against Prostate Cancer with Additional Herbzymatic Activity.

Authors:  Bexultan Kazybay; Qinglei Sun; Kanat Dukenbayev; Ayan Amantaiuly Nurkesh; Na Xu; Aidana Kutzhanova; Madina Razbekova; Anar Kabylda; Qing Yang; Qian Wang; Cuiping Ma; Yingqiu Xie
Journal:  ACS Omega       Date:  2022-04-18

3.  Integrated comparative metabolomics and network pharmacology approach to uncover the key active ingredients of Polygonati rhizoma and their therapeutic potential for the treatment of Alzheimer's disease.

Authors:  Fu Wang; Hongping Chen; Yuan Hu; Lin Chen; Youping Liu
Journal:  Front Pharmacol       Date:  2022-08-04       Impact factor: 5.988

4.  Potential compound from herbal food of Rhizoma Polygonati for treatment of COVID-19 analyzed by network pharmacology: Viral and cancer signaling mechanisms.

Authors:  Chenglin Mu; Yifan Sheng; Qian Wang; Amr Amin; Xugang Li; Yingqiu Xie
Journal:  J Funct Foods       Date:  2020-08-14       Impact factor: 4.451

5.  Clinical data mining on network of symptom and index and correlation of tongue-pulse data in fatigue population.

Authors:  Yulin Shi; Xiaojuan Hu; Ji Cui; Longtao Cui; Jingbin Huang; Xuxiang Ma; Tao Jiang; Xinghua Yao; Fang Lan; Jun Li; Zijuan Bi; Jiacai Li; Yu Wang; Hongyuan Fu; Jue Wang; Yanting Lin; Jingxuan Bai; Xiaojing Guo; Liping Tu; Jiatuo Xu
Journal:  BMC Med Inform Decis Mak       Date:  2021-02-24       Impact factor: 2.796

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.